Search Results
Andrew Callos of Pfizer on building a rare disease franchise at World Orphan Drug Congress USA 2013
Andrew Callos of Pfizer on sustainable business in rare disease at World Orphan Drug Congress USA
Brenda Cooperstone on Pfizer's rare disease portfolio at World Orphan Drug Congress USA 2013
Andrew Callos of Pfizer on sustainable business in rare disease
Freda Lewis-Hall of Pfizer on next gen orphan drugs at World Orphan Drug Congress USA 2013
Rare disease clinical trials with Shire, Novartis and more at World Orphan Drug Congress USA 2013
An EU single orphan drug market with SOBI, EURORDIS and more at World Orphan Drug Congress USA 2013
World Orphan Drug Congress USA 2013 event highlights
Pfizer's Rare Disease Unit - Advancing the Discovery, Development, and Availability of Orphan Drugs
Pfizer's Philosophy for Orphan Drugs - extended cut
Orphan drug discoveries & academic centers of excellence at World Orphan Drug Congress USA
Panel session on global patient registry status updates at World Orphan Drug Congress USA 2013
